Replies to post #122603 on Biotech Values

[masterlongevity]

Gild's current market cap is $33B.

Am assuming JnJ would need to offer at least a 25% premium for a price near $42B. Can they afford that?

JnJ's market cap is $180B. If you assume the pharma division is 1/3, then that market cap is $60B